FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079384857> ?p ?o ?g. }

• W2079384857 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCAnaplastic lymphoma kinase (ALK), when aberrantly regulated through gene translocations or mutations, has been implicated as an oncogenic driver in a variety of cancers. XALKORI (crizotinib) is an FDA-approved therapy for locally advanced or metastatic (ALK)-positive non-small cell lung cancer (NSCLC). Mutations of certain residues within the ALK kinase domain have been associated with crizotinib resistance. To understand the molecular basis of mutational resistance, we have kinetically and structurally characterized several clinical mutations of ALK kinase domain. In the basal-state (nonphosphorylated) proteins, mutations C1156Y, F1174L, L1152R and L1196M resulted in 14 to 52-fold increase in catalytic efficiency of phosphorylation of an activation loop peptide. Accordingly, these mutants were more rapidly autophosphorylated, compared to wild-type enzyme. In addition, F1174L, C1156Y and L1156Y had 2 to 6-fold higher catalytic efficiencies when fully activated by autophosphorylation. Conversely, catalytic efficiencies of nonphosphorylated and phosphorylated G1269A variant decreased by 1.2 and 1.6-fold, respectively. Inhibition of L1152R, L1196M and G1269A by crizotinib was reduced by 3-28-fold, compared to wild-type enzyme, from Ki determinations. From direct binding studies of the L1196M “gatekeeper” mutation, the loss of crizotinib binding occurred 6 and 13-fold for phosphorylated and nonphosphorylated proteins, respectively. By crystallographic studies apoenzyme and crizotinib complexes of ALK kinase domain displayed an inactive kinase conformation that is stabilized by an extended hydrophobic network of residues. F1174 and L1196 are part of this hydrophobic core, and mutations of these residues are predicted to destabilize the inactive ALK conformation. Taken together, these results suggest that most of the resistant mutations (e.g. L1196M, F1174L, C1156Y, L1152R) result in a more dynamic protein that increases substrate turnover. In addition, the reduction of crizotinib binding for the mutations in the vicinity of the inhibitor binding site (L1196M, G1269A) is likely a contributing factor for the resistance. This structural and kinetic analysis of mutational resistance may be useful for design of new inhibitors targeting multiple clinical mutations of ALK.Citation Format: Sergei Timofeevski, Wei Liu, Ya-Li Deng, Alexei Brooun, Simon Bergqvist, Shannon Karlicek, Brion Murray, Ben Bolanos, Michele McTigue. Biochemical and structural characteristics of crizotinib-resistant ALK mutants. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4456. doi:10.1158/1538-7445.AM2013-4456" @default.
• W2079384857 created "2016-06-24" @default.
• W2079384857 creator A5006518535 @default.
• W2079384857 creator A5014095609 @default.
• W2079384857 creator A5016038666 @default.
• W2079384857 creator A5018283590 @default.
• W2079384857 creator A5031081898 @default.
• W2079384857 creator A5038025649 @default.
• W2079384857 creator A5056520253 @default.
• W2079384857 creator A5060346992 @default.
• W2079384857 creator A5071037763 @default.
• W2079384857 date "2013-04-15" @default.
• W2079384857 modified "2023-10-18" @default.
• W2079384857 title "Abstract 4456: Biochemical and structural characteristics of crizotinib-resistant ALK mutants." @default.
• W2079384857 doi "https://doi.org/10.1158/1538-7445.am2013-4456" @default.
• W2079384857 hasPublicationYear "2013" @default.
• W2079384857 type Work @default.
• W2079384857 sameAs 2079384857 @default.
• W2079384857 citedByCount "0" @default.
• W2079384857 crossrefType "proceedings-article" @default.
• W2079384857 hasAuthorship W2079384857A5006518535 @default.
• W2079384857 hasAuthorship W2079384857A5014095609 @default.
• W2079384857 hasAuthorship W2079384857A5016038666 @default.
• W2079384857 hasAuthorship W2079384857A5018283590 @default.
• W2079384857 hasAuthorship W2079384857A5031081898 @default.
• W2079384857 hasAuthorship W2079384857A5038025649 @default.
• W2079384857 hasAuthorship W2079384857A5056520253 @default.
• W2079384857 hasAuthorship W2079384857A5060346992 @default.
• W2079384857 hasAuthorship W2079384857A5071037763 @default.
• W2079384857 hasConcept C104317684 @default.
• W2079384857 hasConcept C117643217 @default.
• W2079384857 hasConcept C126322002 @default.
• W2079384857 hasConcept C143065580 @default.
• W2079384857 hasConcept C150109051 @default.
• W2079384857 hasConcept C153911025 @default.
• W2079384857 hasConcept C184235292 @default.
• W2079384857 hasConcept C185592680 @default.
• W2079384857 hasConcept C207583985 @default.
• W2079384857 hasConcept C2776232967 @default.
• W2079384857 hasConcept C2776256026 @default.
• W2079384857 hasConcept C2778347629 @default.
• W2079384857 hasConcept C2779422266 @default.
• W2079384857 hasConcept C32619005 @default.
• W2079384857 hasConcept C501734568 @default.
• W2079384857 hasConcept C502942594 @default.
• W2079384857 hasConcept C55493867 @default.
• W2079384857 hasConcept C71924100 @default.
• W2079384857 hasConcept C86803240 @default.
• W2079384857 hasConcept C97029542 @default.
• W2079384857 hasConceptScore W2079384857C104317684 @default.
• W2079384857 hasConceptScore W2079384857C117643217 @default.
• W2079384857 hasConceptScore W2079384857C126322002 @default.
• W2079384857 hasConceptScore W2079384857C143065580 @default.
• W2079384857 hasConceptScore W2079384857C150109051 @default.
• W2079384857 hasConceptScore W2079384857C153911025 @default.
• W2079384857 hasConceptScore W2079384857C184235292 @default.
• W2079384857 hasConceptScore W2079384857C185592680 @default.
• W2079384857 hasConceptScore W2079384857C207583985 @default.
• W2079384857 hasConceptScore W2079384857C2776232967 @default.
• W2079384857 hasConceptScore W2079384857C2776256026 @default.
• W2079384857 hasConceptScore W2079384857C2778347629 @default.
• W2079384857 hasConceptScore W2079384857C2779422266 @default.
• W2079384857 hasConceptScore W2079384857C32619005 @default.
• W2079384857 hasConceptScore W2079384857C501734568 @default.
• W2079384857 hasConceptScore W2079384857C502942594 @default.
• W2079384857 hasConceptScore W2079384857C55493867 @default.
• W2079384857 hasConceptScore W2079384857C71924100 @default.
• W2079384857 hasConceptScore W2079384857C86803240 @default.
• W2079384857 hasConceptScore W2079384857C97029542 @default.
• W2079384857 hasLocation W20793848571 @default.
• W2079384857 hasOpenAccess W2079384857 @default.
• W2079384857 hasPrimaryLocation W20793848571 @default.
• W2079384857 hasRelatedWork W1601293742 @default.
• W2079384857 hasRelatedWork W1987944258 @default.
• W2079384857 hasRelatedWork W2019611572 @default.
• W2079384857 hasRelatedWork W2030702185 @default.
• W2079384857 hasRelatedWork W2035476809 @default.
• W2079384857 hasRelatedWork W2066522006 @default.
• W2079384857 hasRelatedWork W2105699883 @default.
• W2079384857 hasRelatedWork W2320283852 @default.
• W2079384857 hasRelatedWork W2338990099 @default.
• W2079384857 hasRelatedWork W2401921569 @default.
• W2079384857 hasRelatedWork W2504123697 @default.
• W2079384857 hasRelatedWork W2554459482 @default.
• W2079384857 hasRelatedWork W2562057618 @default.
• W2079384857 hasRelatedWork W2563883702 @default.
• W2079384857 hasRelatedWork W2739890533 @default.
• W2079384857 hasRelatedWork W2887622849 @default.
• W2079384857 hasRelatedWork W2965978995 @default.
• W2079384857 hasRelatedWork W3179610562 @default.
• W2079384857 hasRelatedWork W3179626056 @default.
• W2079384857 hasRelatedWork W4226440628 @default.
• W2079384857 isParatext "false" @default.
• W2079384857 isRetracted "false" @default.
• W2079384857 magId "2079384857" @default.
• W2079384857 workType "article" @default.